In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.

Twelve patients with small cell lung cancer were treated with recombinant human granulocyte colony-stimulating factor, rhG-CSF, given by continuous infusion at doses ranging from 1 to 40 micrograms kg-1 day-1. Patients received the rhG-CSF before the start of intensive chemotherapy and after alterna...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bronchud, M. H., Potter, M. R., Morgenstern, G., Blasco, M. J., Scarffe, J. H., Thatcher, N., Crowther, D., Souza, L. M., Alton, N. K., Testa, N. G.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1988
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2246501/
https://ncbi.nlm.nih.gov/pubmed/2458748
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires